Business programme

6 June 09:00–10:15
Broadcast
Beating Lung Cancer. Innovative Diagnosis and Treatment Methods
Lung cancer is the leading cause of cancer deaths worldwide and a major global health challenge. Estimates from the International Agency for Research on Cancer calculated based on data from 185 countries show that lung cancer accounted for 12.4% of the total number of newly diagnosed cancer cases in 2022 and 18.7% of total deaths from cancer, which is approximately 2.5 and 1.8 million people, respectively. The healthcare system’s priority goals in preventing lung cancer are to vastly increase the detection and treatment of the disease in its early stages, as well as the number of studies to identify innovative methods of therapy using advanced scientific achievements, including personalized high-tech medicine. In this regard, the government and the professional community need to work together to significantly increase the life chances of patients in an effort to improve primary prevention measures, expand the criteria and opportunities for implementing cancer screening programmes as part of clinical examinations in all regions of Russia, and utilize the power of artificial intelligence to interpret the results of diagnostic studies. What programmes for the prevention, detection, and treatment of lung cancer have proven to be the most effective in Russia and around the world? What innovative drugs and methods of treating lung cancer have already been introduced and will appear in the near future? What opportunities exist today for implementing lung cancer screening programmes as a tool for reducing mortality from malignant tumours? What successful global best practices in organizing programmes to prevent and treat lung cancer can be applied in Russia?
Moderator:
Alexey Belyaev — Director, N.N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
D. M. Sc., Professor.
Director of the Federal State Budgetary Institution “N.N. Petrov National Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation.
Since 2012 he is the Director of the Research Institute of Oncology.
Belyaev Aleksey Mikhaylovich is the main freelance oncologist of the Northwestern Federal District, Head of the Department of Oncology of the Mechnikov North-West State Medical University, Chairman of Oncologists Association of the Northwestern Federal District, Doctor of Medical Science, Professor.
Education:
1986 – graduated with honors and gold medal the “S.M. Kirov Military Medical Academy.”
1992 – postgraduate studies in a military college (graduate work) at the “S.M. Kirov Military Medical Academy”.
Research and practice activity:
1993 – passed the Ph.D. defense “Morphofunctional characteristics of soft tissues around of the gunshot wound (ballistic trauma)”
2004 – passed thesis for the doctor’s degree “Cytoreductive surgeries and hyperthermic intraperitoneal chemotherapy in the complex treatment of common forms of abdominal cancer”.
Since 1998 he has been developing problems of care for patients with advanced forms of peritoneal cancer. Belyaev Aleksey Mikhaylovich is one of the first in Russia, who began to perform cytoreductive surgeries with chemohyperpyretic perfusions of abdominal cavity. He is awarded the Diploma of the Ministry of Health of the Russian Federation and the Plaque “Excellent Worker of Public Health”, he has the Medal “For Merit to Domestic Health Care”.
Belyaev Aleksey Michaylovich is the author more than 200 research papers and one monograph. 10 Ph.D. defenses and 3 theses for a doctor degree were passed under his leadership.
Panellists:
Yan Vlasov — Co-Chairman, Russian Patient Association
Yan Vladimirovich Vlasov
Born on 11/16/1967 in Kuibyshev, RSFSR.
Profile
Co-chair of the Russian Patients Association; President of the Russian Multiple Sclerosis Society; Chair of the Council of Non-Governmental Patient Advocacy Organizations under the Federal Service for Supervision in Healthcare; Head of Healthcare Commission at the Social Council of Rosatom State Atomic Energy Corporation; Deputy Chair of the Social Council at the Federal Medical-Biological Agency of Russia; member of the Council of Non-Governmental Patient Advocacy Organizations under the Ministry of Health of the Russian Federation; member of the Ethics Council of the Ministry of Health of the Russian Federation; member of the Ethics Committee of the Ministry of Health of the Russian Federation; member of the Central Staff of All-Russia People’s Front (ONF); member of the Presidential Working Group for the Development of Civil Society and Human Rights; member of the Working Group at the Council of Federation Committee on Social Policy. Holder of Habilitation degree in Medicine (specialty in neurologic diseases). Professor of the Department of Neurology and Neurosurgery of Samara State Medical University.
Married, 5 children.
Tracy Guo — Chief Globalization Officer, Linkdoc
Ruslan Zukov — Chief physician, «Krasnoyarsk Regional Clinical Oncology Center named after A.I. Kryzhanovsky»
Evgeny Kamkin — Deputy Minister of Health of the Russian Federation
Wenhua Liang — Assistant Director of Oncological Dept. (Prof. Jianxing He); Secretary General and Chairman of Immunotherapy Committee of Guangdong Association of Thoracic Disease; A/Director of LC group of Chinese national clinical research center for respiratory; Member of China Clinical Trial Consortium (CCTC), ASCO, ESMO and IASLC; Associate Editor of Transl Lung Cancer Res (IF 6.498) Editorial Board Member of J Thorac Dis & Ann Transl Med
M.D., A/Chief Physician, A/Professor, PhD Tutor, Pearl-River Scholar
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Born July 27, 1964 in Obninsk, Kaluga Oblast.
In 1987, he graduated from the Pirogov Russian National Research Medical University with a degree in General Medicine. After graduation he stayed in the university, where he rose from postgraduate to professor of the department of clinical pharmacology.
In 1998 he graduated from the Russian Presidential Academy of National Economy and Public Administration of the Russian Federation with a degree in state and municipal management, with the qualification of economist-financier.
In 2002, he defended the first doctoral dissertation in the Russian Federation on clinical and economic analysis and pharmacoeconomics.
From 2009 to 2012 he was. - Vladimir Potanin was Director of the Research Institute for Clinical and Economic Expertise and Pharmacoeconomics at the N.I. Pirogov Russian National Research Medical University, Federal State Autonomous Educational Institution of Higher Professional Education, Ministry of Health Care of the Russian Federation.
From 2012 to 2020, she was Head of the Research Laboratory of the N.I. Pirogov Russian National Research Medical University. - Head of the Research Laboratory for Technology Assessment in Healthcare at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, a federal state budget-funded educational institution of higher education.
Since 2014. - Head of the Healthcare Finance Center of the Federal State Budgetary Institution "Research Financial Institute" of the Ministry of Finance of the Russian Federation. Ministry of Finance of the Russian Federation.
Since 2015. - General Director of the Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" of the Ministry of Health of the Russian Federation.
Since 2020. - Head of the Department of Economics, Management and Assessment of Healthcare Technologies of the Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuing Professional Education" of the Ministry of Healthcare of the Russian Federation.

Member of the Dissertation Council D 208.088.01.
Head of the Expert Council on Health Care of the Federation Council Committee on Social Policy, Expert of the Analytical Centre for the Government of the Russian Federation.
Chief Clinical Pharmacologist, Ministry of Health, Moscow Region.
Chief editor of scientific journals, Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology" and "Medical Technology. Evaluation and Choice".
She is an author of three patents of the Russian Federation, two monographs, educational and methodical manuals for physicians, and more than 140 scientific papers published in Russian and foreign medical journals.
Doctor of Medicine (2002), Professor (2007). Under his supervision V.V. Omelyanovsky defended one doctoral thesis and seven Ph. Currently supervises the theses of two doctoral students and two doctoral candidates.
He is the President of the Russian branch of the International Society for Pharmacoeconomic Research and Outcome Evaluation (ISPOR).
He is a laureate of the Russian Federation Government Award in Science and Technology, has certificates of merit from the President of the Russian Federation and the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, and has received commendations from the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, the Analytical Center of the Russian Federation Government, the Russian Academy of National Economy and Public Administration under the President of the Russian Federation, and the Sverdlovsk Oblast Government.
Igor Tyurin — Chief freelance specialist in radiation and instrumental diagnostics of the Ministry of Health of the Russian Federation; Deputy Director, Research Institute of Clinical and Experimental Radiology, Federal State Budgetary Institution "Scientific Medical Research Center of Oncology named after Nikolai Nikolaevich Blokhin" of the Ministry of Health of the Russian Federation; Head of the Department of Radiology and Radiology, Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation
Petr Yablonsky — Professor, Vice-Rector for Medical Activities, Head of the Department of Hospital Surgery, St. Petersburg State University
6 June 13:00–14:15
Broadcast
Intellectual Property in Pharmaceuticals: Fight or Discussion?
Issues concerning intellectual property in the pharmaceutical industry are particularly acute, since effective legal regulation and enforcement in the industry directly affects how Russia protects the life and health of the population and the country’s drug independence. The rapid development of domestic pharmaceuticals has made it crucial to improve legal mechanisms, balance the interests of foreign copyright holders and domestic manufacturers, and harmonize the approaches that domestic and foreign intellectual property institutions take to establishing and extending patent protection. What gaps currently exist in patent regulation? What kind of support is available for domestic full-cycle manufacturers in terms of intellectual property issues? Can unified approaches be developed to the use of the compulsory licensing mechanism? What patent strategies of manufacturers and initiatives of regulators are optimal as Russia phases out imports of foreign medical products?
Moderator:
Alevtina Penkalskaya — Financial Observer, RBC Investments; Presenter, RBC-TV
Panellists:
Petr Bely — Founder and Chairman of the Board of Directors, Promomed Group
Founder and Chairman of the Board of Directors of Promomed Group, medical doctor. Petr Bely has more than 25 years of experience in the medical sector and has held senior positions in a number of large pharmaceutical companies. In 2005, he established the Promomed company and in a few years turned it into one of the most dynamically growing players in the Russian pharmaceutical market. Petr Bely regularly participates in scientific forums, conferences and other industry events. He is the author of numerous scientific publications. In March 2021, he was awarded the Pirogov Order for his merits in the field of drug production.

Education:

— Moscow State Medical and Dental University, "Medicine" specialty, training in clinical residency and a full course in "Therapeutics" specialty;
— Candidate of Medical Sciences in the "Internal diseases" specialty.
Sergey Glagolev — Deputy Minister of Health of the Russian Federation
Artem Zdunov — Head of the Republic of Mordovia
Education:
2000: Kazan State Financial and Economic Institute (KSFEI, now part of Kazan (Volga region) Federal University
Degree: Finance and Credit
2004: Postgraduate course at KSFEI
2011: Master's Degree from the Russian Presidential Academy of National Economy and Public Administration (RANEPA) in State and Public Administration
2012, 2016, 2017: Advanced training courses at RANEPA in Managing Innovative Development of Industries and Regions, Managerial Skills: Developing Regional Teams, and Application of Flexible Project Management Methods in Russian Authorities.
Graduate of the first stage of the Management Personnel Pool for the Civil Service program (the so-called school of governors)

2005: PhD in Economics from KSFEI
Thesis: Capital Outflow in the System of Economic Security of Modern Russia

Career:
September 1996-October 1998: Deputy Chairman of the student trade union, Kazan State University of Economics and Finance

June 2000-March 2001: Insurance specialist and internal auditor at Industrial Insurance Company, Kazan

2004-2006: Lecturer, Department of Macroeconomics and Economic Theory, Kazan State Financial and Economic Institute

July 2006-May 2010: Deputy director for research, Center for Advanced Economic Research, the Academy of Sciences of Tatarstan

May 2010-October 2014: Deputy Minister of the Economy of Tatarstan

October 2014-February 2018: Minister of the Economy of Tatarstan

February 7, 2018-2020: Chairman of the Government of the Republic of Dagestan

November 18, 2020: Appointed Acting Head of the Republic of Mordovia by an executive order of President of Russia Vladimir Putin

Awards:
Winner of the contest of the Academy of Sciences of Tatarstan for Best Scientist of 2009

Fluent in English
2009: International business English certificate from Cambridge University, United Kingdom
Yury Zubov — Head, Federal Service for Intellectual Property (Rospatent)
Born on 20 April 1979 in Moscow.
In 2001 Mr. Zubov graduated from the Moscow State University of Culture and Arts, Faculty of Management and Social Information Technologies, the specialty in Information Systems in Social and Cultural Field. Candidate of pedagogical sciences.
From 2000 to 2008 he held management positions related to business development in LLC "Trading House BIBLO-GLOBUS" and was a member of the Supervisory Board of "BIBLIO-GLOBUS" Holding Group.
From 2008 to 2012 he served as Head of Division for Science, Innovation and Information Technology in the Department for Science and Education of the Ministry of Culture of the Russian Federation.
In 2009 Mr. Zubov was promoted to the rank of Third Class State Civil Service Councellor of the Russian Federation.
In 2013 he served as Deputy Head of Department and Head of Division for Monitoring Quality Assessment of Vocational Education in the Department of Public Services of the Federal Service for the Supervision of Education and Science (ROSOBNADZOR).
From 2013 to 2016 Mr. Zubov served as Deputy Head of Division for Information Technologies in the Federal State Unitary Enterprise "Main Production and Commercial Administration for Diplomatic Corps Services at the Ministry of Foreign Affairs of the Russian Federation".
From 2016 to 2018 he worked as Director of the Federal State Budget Institution "Federal Institute of Industrial Property" (FIPS).
From 2018 to 2022 he served as Deputy Head of the Federal Service for Intellectual Property (Rospatent).
In 2020 he was promoted to the rank of Third Class Active State Counsellor of the Russian Federation.
In February 2022 he was appointed as Head of Rospatent.
Vyacheslav Shulenin — General Director, Moscow Center for Healthcare Innovations
6 June 14:45–16:00
Broadcast
Advanced Pharmaceuticals in Russia: Unique Developments, New Technologies, and Industry Leadership
The pharmaceutical industry is one of the priority focuses for development of the national social policy, the economy, and the global market. Given Russia’s current foreign policy challenges and desire to be independent of imports, the country’s advanced pharmaceuticals are trending upwards in terms of developing and applying innovative technologies and IT solutions to automate key economic sectors, develop promising biotechnologies, and create effective new types of medicines. In 2023, Russian pharmaceutical companies demonstrated steady growth and accounted for more than 36% of the national market in rouble terms, concentrating not only on the production of safe and high-quality medicines – generics – that the population needs due to the forced substitution of imports, but also on the production of unique modern endocrinological, neurological, rheumatological, antibacterial, and other drugs. How has the Russian national pharmaceutical market changed over the past year? What challenges does the pharmaceutical industry face in terms of providing the population with high-tech medicinal products? What measures could encourage private investors to invest in the shares of pharmaceutical companies? What biotechnologies will drive the development of the modern pharmaceutical industry in the near future? How can we effectively use IT technologies and artificial intelligence to develop new drugs? What incentives exist for developing the scientific and technological capabilities of pharmaceutical companies?
Moderator:
Alevtina Penkalskaya — Financial Observer, RBC Investments; Presenter, RBC-TV
Panellists:
Petr Bely — Founder and Chairman of the Board of Directors, Promomed Group
Founder and Chairman of the Board of Directors of Promomed Group, medical doctor. Petr Bely has more than 25 years of experience in the medical sector and has held senior positions in a number of large pharmaceutical companies. In 2005, he established the Promomed company and in a few years turned it into one of the most dynamically growing players in the Russian pharmaceutical market. Petr Bely regularly participates in scientific forums, conferences and other industry events. He is the author of numerous scientific publications. In March 2021, he was awarded the Pirogov Order for his merits in the field of drug production.

Education:

— Moscow State Medical and Dental University, "Medicine" specialty, training in clinical residency and a full course in "Therapeutics" specialty;
— Candidate of Medical Sciences in the "Internal diseases" specialty.
Sergey Zhdanov — Managing Director, Director of the Health Industry Center, Sberbank
Kamila Zarubina — Vice President, Executive Director of the Cluster of Biological and Medical Technologies, Skolkovo Foundation
Artem Zdunov — Head of the Republic of Mordovia
Education:
2000: Kazan State Financial and Economic Institute (KSFEI, now part of Kazan (Volga region) Federal University
Degree: Finance and Credit
2004: Postgraduate course at KSFEI
2011: Master's Degree from the Russian Presidential Academy of National Economy and Public Administration (RANEPA) in State and Public Administration
2012, 2016, 2017: Advanced training courses at RANEPA in Managing Innovative Development of Industries and Regions, Managerial Skills: Developing Regional Teams, and Application of Flexible Project Management Methods in Russian Authorities.
Graduate of the first stage of the Management Personnel Pool for the Civil Service program (the so-called school of governors)

2005: PhD in Economics from KSFEI
Thesis: Capital Outflow in the System of Economic Security of Modern Russia

Career:
September 1996-October 1998: Deputy Chairman of the student trade union, Kazan State University of Economics and Finance

June 2000-March 2001: Insurance specialist and internal auditor at Industrial Insurance Company, Kazan

2004-2006: Lecturer, Department of Macroeconomics and Economic Theory, Kazan State Financial and Economic Institute

July 2006-May 2010: Deputy director for research, Center for Advanced Economic Research, the Academy of Sciences of Tatarstan

May 2010-October 2014: Deputy Minister of the Economy of Tatarstan

October 2014-February 2018: Minister of the Economy of Tatarstan

February 7, 2018-2020: Chairman of the Government of the Republic of Dagestan

November 18, 2020: Appointed Acting Head of the Republic of Mordovia by an executive order of President of Russia Vladimir Putin

Awards:
Winner of the contest of the Academy of Sciences of Tatarstan for Best Scientist of 2009

Fluent in English
2009: International business English certificate from Cambridge University, United Kingdom
Ekaterina Priezzheva — Deputy Minister of Industry and Trade of the Russian Federation
Denis Shulakov — First Vice President, Gazprombank
Denis Shulakov is the First Vice-President of Gazprombank since September 2012, in charge of capital markets across international and domestic debt, equity and equity-linked products as well as trading, brokerage and market research. Over the last 3 years Gazprombank has established itself within top 5 bookrunners for Russian eurobonds and #1 bonds arranger in Russian Oil&Gas and Energy industries (Gazprom, Gazpromneft, Novatek, Rosneft, Sibur, Federal Grid mandates executed).
Prior to joining Gazprombank Denis worked as a Managing Director of Barclays in London (2003-2012) heading Russian investment banking and lately CIS public sector. During this time, Barclays became the #1 bookrunner for Russian Eurobonds (2010) and was among top-3 bookrunners for a number of consecutive years. Denis managed over 70 eurobond placements and liability management mandates for largest Russian and CIS clients, including re-entry of the Russian Federation in theEurobond market in 2010, debut international debt offerings of Vhesheconombank, Russian Development Bank and Russian Railways, numerous eurobond issues for Lukoil including USD1.5bn convertible bonds in 2010, loan portfolio restructuring of Rosneft with USD7.5bn pre-IPO bridge financing, IPO and debut eurobonds, rating advisory, positioning of Ukrainian Railways for international debt issue and many others.
Front row participant:
Artur Isaev — Founder, Chairman of the Board of Directors, Artgen Biotech
6 June 16:30–17:45
Broadcast
Focus on Health: The Corporate and Social Initiatives of Russian Companies
Health is an invaluable resource for individuals, society, and countries as a whole. The well-being of employees directly affects their productivity, and the opportunity to remain healthy with their employer’s support increases loyalty. Investing in innovative approaches to prevent diseases is a crucial task, as well as an opportunity and huge market for the products and services of Russian companies. The current trend is that most companies not only care about their employees, but also about their families. Modern socially responsible businesses and non-profits are responsible for raising awareness about shared responsibility for solving such challenges as preserving a good quality of life of the working-age population, as well as the population’s constant involvement in projects to cultivate awareness. What new solutions will improve health in Russia? How can we improve employees’ health and the quality of their life? How are corporate voluntary health insurance programmes becoming an important factor in attracting the best talent? How do corporate sports affect companies? What social initiatives have proven to be the most in-demand? Why is concern for preserving the working population’s quality of life the shared task of businesses, partner non-profits, and employees themselves?
Moderator:
Andrey Levchenko — Presenter, RBC TV Channel
Panellists:
Ekaterina Genkina — Deputy General Director for Change Management, NPS Group of Companies
Ekaterina Glebova — Director of Social Projects, Medscan Group (Hadassah Medical Moscow)
Oxsana Pozdnyakova — General Director, Nizhpharm
Larisa Popovich — Director, Institute for Health Economics, National Research University Higher School of Economics
Education: MSU (Higher nervous activity biologist-physiologist), Academy of the National Economy under the Government of the Russian Federation (Economics, finance and insurance), the Federal Supervision Service for Healthcare of the Russian Federation (Public health and organisation of healthcare), CSc (biology). Has been a WHO expert.
Up to 1997: worked at scientific institutions of the Academy of Sciences and the Academy of Medical Sciences.
1997–2009: ROSNO-MS insurance company (Senior Deputy General Director, member of the Board of Directors).
Since 2009: the Higher School of Economics National Research University (expert, scientific and educational activities). Key clients: Government of the RF and authorities of constituent entities of the RF.
Experience of public work:
• Member of the Expert Council of the Russian Government.
• Expert of the Strategic Initiative Agency.
• Head of working group of the Co-ordinating Committee for Public-private Partnership, Ministry of Health of the RF.
• Head of commission of the Public Council under the Federal Supervision Service for Healthcare of the Russian Federation (Roszdravnadzor).
Professional interests:
• organisation and economic of healthcare;
• modern medical and social technologies;
• social and medical insurance;
• provision of medicines and medical equipment;
• public-private partnership in the social sphere.
Olga Sorokina — Member of the Board of Directors, Deputy General Director for Business Development, VSK Insurance House
Anna Sorochinskaya — Executive Director, NGO "Public Council on the problem of adolescent smoking"
Alexander Filippov — Member of the Board, All-Russian public organization "National Society for the Study of Atherosclerosis"
Front row participants:
Eric Brovko — Social Entrepreneur; Founder and CEO, Health.ru; Partner, Youtalk; Member of the Public Council of the Ministry of Health of the Russian Federation
Natalia Darbinyan — Head of Communications, Support of Healthcare National Project, Natsionalnye Prioritety ANPO
Alexander Kalinin — President, All‑Russian Non‑Governmental Organization of Small and Medium‑Sized Businesses OPORA RUSSIA
Born on November 4, 1966 in the city of Chelyabinsk.
In 1989 graduated with honors from the Chelyabinsk Polytechnic Institute, specialization in robototronics, diploma qualification in electrical engineering.
From 1989 to 1991 has undertaken postgraduate training program at the Department of Engineering Economics of the Chelyabinsk Polytechnic Institute.
In 1991 founded a wholesale and retail company engaged in export and import operations. Fluent in spoken English.
In 1995-1998 has graduated from the Ural Academy of Public Administration with a degree in law.
In 1998 invested in the creation of a manufacturing company. The company designs and manufactures motor control centers, co-author of an invention patent.
In 2002 became a founding member of All-Russian Non-Governmental Organization of Small and Medium Business “OPORA RUSSIA”.
In 2005 was elected Chairman of the Chelyabinsk regional office of “OPORA RUSSIA”.
In 2007 was elected to the Board of “OPORA RUSSIA”.
In 2012 was elected first Vice-President of “OPORA RUSSIA” on energy, infrastructure and cluster policy.
Since 2013 – member of the Government Commission on Electric Power Development.
In 2013 was elected Co-Chairman of the Staff of the Chelyabinsk regional branch of the All-Russian Public Movement “People's Front” for Russia!”
Since 2014 – member of the Board of Directors of JSC “ROSSETI” (June 2014), member of the Board of Directors of RAO “UES” (August 2014).
October 29, 2014 was elected President of All-Russian Non-Governmental Organization of Small and Medium Business “OPORA RUSSIA” and Non-Profit Partnership “OPORA”
Awarded with certificates of acknowledgement of the Presidential Administration, Government of the Russian Federation, Federal Assembly of the Russian Federation, Ministry of Economic Development of the Russian Federation, Governor of the Chelyabinsk Region, Legislative Assembly of the Chelyabinsk region.